Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Rubinstein Julie sold 57,180 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Apr 9 to Apr 13, 2026 · Filed Apr 13, 2026

From Apr 9 to Apr 13, 2026, Rubinstein Julie (President and COO) sold 57,180 Adaptive Biotechnologies Corporation shares at an average US$13.26 for US$758K under a trading plan, leaving 421,174 shares. Filed Apr 13, 2026 (Form 4).

Sold
57,180 shares
Price
US$13.26 average (US$12.75 to US$14.44)
Value
US$758K
Holding after
421,174 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President and COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 9, 2026Common StockOption exercise14,722US$7.27448,910Direct
Apr 9, 2026Common StockSale16,960US$13.79431,950Direct
Apr 9, 2026Common StockSale2,100US$14.44429,850Direct
Apr 10, 2026Common StockOption exercise14,722US$7.27444,572Direct
Apr 10, 2026Common StockSale18,660US$12.75425,912Direct
Apr 10, 2026Common StockSale400US$13.48425,512Direct
Apr 13, 2026Common StockOption exercise8,109US$7.27433,621Direct
Apr 13, 2026Common StockOption exercise6,613US$8.46440,234Direct
Apr 13, 2026Common StockSale15,722US$12.95424,512Direct
Apr 13, 2026Common StockSale3,338US$14.08421,174Direct

Source

View original at SEC

Related